ArticleEuropean radiology2026
Feasibility of BMI-based sub-milliSievert low-dose CT in individualized detection of lung nodules.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
Abstract
objectivesTo evaluate the performance of a body mass index (BMI)-based sub-milliSievert low-dose CT (LDCT) protocol with multiple reconstruction algorithms for image quality and lung nodule assessment. MATERIALS AND
methodsThis prospective study included 214 participants who underwent standard-dose CT (SDCT, 3.68 ± 1.53 mSv) reconstructed with 50% adaptive statistical iterative reconstruction (ASIR-V-50%) and LDCT. LDCT was randomly divided into a higher-dose group (LD-A, 0.57-1.15 mSv, n = 108) and a lower-dose group (LD-B, 0.33-0.63 mSv, n = 106). Each group was stratified into four BMI-based subgroups with individualized protocols reconstructed with deep learning image reconstruction (DLIR-H and DLIR-M), ASIR-V-50%, and filtered back projection (FBP). Image quality, nodule detection across BMI subgroups, and the performance of four algorithms in detection, size measurement accuracy, and Lung-RADS v2022 consistency were analyzed.
resultsIn LDCT, DLIR-H provided superior image quality (p < 0.001) and the highest overall nodule detection rate (99.04%), surpassing ASIR-V-50% (98.55%) and FBP (97.87%) (both p < 0.05). The advantage was most evident for nodules < 6 mm, while all nodules ≥ 6 mm were consistently detected across algorithms. Detection rates showed no significant variation among BMI subgroups (all p > 0.05). For measurement accuracy, FBP and ASIR-V-50% performed better in LD-A (all p < 0.05), whereas DLIR-M was superior in LD-B (p < 0.001). All algorithms demonstrated excellent Lung-RADS agreement (κ > 0.9, p < 0.001).
conclusionA BMI-based sub-milliSievert LDCT protocol significantly reduced radiation exposure while maintaining nodule detection across BMI subgroups, with DLIR offering superior image quality and diagnostic performance. KEY POINTS: Question Evidence remains scarce on BMI-based sub-milliSievert low-dose CT using different reconstruction algorithms, regarding image quality and nodules detection (particularly < 6 mm). Findings BMI-based sub-milliSievert low-dose CT ensured balanced detectability across populations, while deep learning reconstruction improved image quality and achieved excellent sensitivity for lung nodule detection. Clinical relevance Deep learning reconstruction enhanced BMI-based sub-milliSievert low-dose CT, supporting its application in personalized sub-milliSievert low-dose lung cancer screening.
Indexed as
Identifiers
41691132What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.